(Q38438830)

3 September 2017

title

Long-term outcome of living donor liver transplantation for patients with alcoholic liver disease (English)

1 reference

3 September 2017

C-S Ahn

1

1 reference

3 September 2017

S Hwang

2

1 reference

3 September 2017

K-H Kim

3

1 reference

3 September 2017

D-B Moon

4

1 reference

3 September 2017

T-Y Ha

5

1 reference

3 September 2017

G-W Song

6

1 reference

3 September 2017

D-H Jung

7

1 reference

3 September 2017

G-C Park

8

1 reference

3 September 2017

S-H Kang

9

1 reference

3 September 2017

B-H Jung

10

1 reference

3 September 2017

N Kim

11

1 reference

3 September 2017

S-G Lee

12

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 April 2014

1 reference

Transplantation Proceedings

3 September 2017

published in

1 reference

3 September 2017

volume

46

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

761-766

1 reference

Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Liver transplantation in patients with alcoholic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Alcohol and substance use in liver transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Efficacy of 6-month pretransplant abstinence for patients with alcoholic liver disease undergoing living donor liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Toward more than 400 liver transplantations a year at a single center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Standardization of modified right lobe grafts to minimize vascular outflow complications for adult living donor liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

MELD accurately predicts mortality in patients with alcoholic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Liver transplantation in alcoholic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Liver transplantation for alcoholic liver disease: current concepts and length of sobriety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Histological features after liver transplantation in alcoholic cirrhotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Adult-to-adult living donor liver transplant: UK experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

The psychiatric assessment of liver transplant patients with alcoholic liver disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Evaluation and selection of the patient with alcoholic liver disease for liver transplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Liver transplantation using hepatitis B core antibody-positive grafts: review and university of Tokyo experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2013.12.032

10.1016/J.TRANSPROCEED.2013.12.032

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference